Garrie Richardson - Oct 19, 2023 Form 3 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Chief Revenue Officer
Signature: /s/ Garrie Richardson
Stock symbol: BLFS
Transactions as of: Oct 19, 2023
Transactions value $: $0
Form type: 3
Date filed: 11/1/2023, 05:29 PM
Next filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BLFS	Common Stock						69K	Oct 19, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BLFS	Restricted Stock Award							Oct 19, 2023	Common Stock	36.3K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount represented in Column 2 of Table I includes 69,007 shares of the Company's restricted stock granted on October 1, 2020 pursuant to the BioLife Solutions 2013 Performance Incentive Plan, as amended (the "Plan"), which vests in equal quarterly installments.
F2	The restricted stock was granted pursuant to the 2023 Omnibus Performance Incentive Plan. The restricted stock will vest 25% on the first anniversary of the grant date and thereafter annually in four equal installments. The restricted stock was granted to the reporting person as a part of their appointment to the position of Chief Revenue Officer.